Prognostic and Predictive Roles for Circulating Biomarkers in Gastrointestinal Cancer
- 23 November 2011
- journal article
- review article
- Published by Taylor & Francis in Future Oncology
- Vol. 7 (12) , 1385-1397
Abstract
Circulating tumor cells (CTCs) and circulating free DNA (cfDNA) have been studied as promising prognostic and predictive tumor-derived biomarkers in the bloodstream of patients with gastrointestinal malignancies because they may be an alternative noninvasive tool to tumor tissue biopsies. Quantification and molecular characterization of CTCs and cfDNA may provide additional insights into cancer biology, potentially revealing novel targets to individualize cancer care. The present article aims to review the biology and current methods to assess CTCs and cfDNA, and the efforts to establish both tumor-derived biomarkers as prognostic and predictive factors in esophageal, gastric and colorectal cancer.Keywords
This publication has 93 references indexed in Scilit:
- Targeting IGF-1R: throwing out the baby with the bathwater?British Journal of Cancer, 2011
- Prediction of CCND1 amplification using plasma DNA as a prognostic marker in oesophageal squamous cell carcinomaBritish Journal of Cancer, 2010
- Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: a systematic reviewBritish Journal of Cancer, 2010
- Decoding Circulating Nucleic Acids in Human Serum Using Microfluidic Single Molecule SpectroscopyJournal of the American Chemical Society, 2010
- Circulating mutant DNA to assess tumor dynamicsNature Medicine, 2008
- Detection of Mutations inEGFRin Circulating Lung-Cancer CellsNew England Journal of Medicine, 2008
- Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancerCancer Letters, 2008
- Isolation of rare circulating tumour cells in cancer patients by microchip technologyNature, 2007
- The effects of preoperative chemotherapy on isolated tumour cells in the blood and bone marrow of gastric cancer patientsBritish Journal of Cancer, 2007
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast CancerNew England Journal of Medicine, 2004